PNC Financial Services Group’s Genmab GMAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$821K Buy
23,017
+1,296
+6% +$41K ﹤0.01% 1442
2026
Q2
$597K Sell
21,721
-1,106
-5% -$29.4K ﹤0.01% 1574
2026
Q1
$612K Sell
22,827
-557
-2% -$16.7K ﹤0.01% 1459
2025
Q4
$720K Buy
23,384
+3,256
+16% +$101K ﹤0.01% 1337
2025
Q3
$617K Buy
20,128
+4,538
+29% +$111K ﹤0.01% 1409
2025
Q2
$322K Sell
15,590
-67,596
-81% -$1.39M ﹤0.01% 1756
2025
Q1
$1.63M Buy
83,186
+15,778
+23% +$331K ﹤0.01% 923
2024
Q4
$1.41M Sell
67,408
-8,302
-11% -$182K ﹤0.01% 977
2024
Q3
$1.85M Sell
75,710
-4,965
-6% -$133K ﹤0.01% 895
2024
Q2
$2.03M Sell
80,675
-5,577
-6% -$158K ﹤0.01% 853
2024
Q1
$2.58M Sell
86,252
-44,873
-34% -$1.32M ﹤0.01% 776
2023
Q4
$4.18M Buy
131,125
+3,757
+3% +$118K ﹤0.01% 645
2023
Q3
$4.49M Buy
127,368
+4,600
+4% +$175K ﹤0.01% 614
2023
Q2
$4.67M Buy
122,768
+5,849
+5% +$233K ﹤0.01% 619
2023
Q1
$4.41M Sell
116,919
-4,672
-4% -$180K ﹤0.01% 623
2022
Q4
$5.15M Sell
121,591
-31,252
-20% -$1.29M 0.01% 575
2022
Q3
$4.91M Sell
152,843
-14,585
-9% -$512K 0.01% 583
2022
Q2
$5.44M Buy
167,428
+1,119
+0.7% +$36.3K 0.01% 571
2022
Q1
$6.02M Sell
166,309
-22,380
-12% -$768K 0.01% 588
2021
Q4
$7.46M Sell
188,689
-7,905
-4% -$330K 0.01% 554
2021
Q3
$8.52M Sell
194,917
-1,863
-0.9% -$83.6K 0.01% 490
2021
Q2
$8.03M Buy
196,780
+63,595
+48% +$2.45M 0.01% 508
2021
Q1
$4.37M Sell
133,185
-57,149
-30% -$2.15M 0.01% 625
2020
Q4
$7.74M Buy
190,334
+5,301
+3% +$198K 0.01% 478
2020
Q3
$6.77M Buy
185,033
+71,092
+62% +$2.57M 0.01% 487
2020
Q2
$3.86M Buy
113,941
+105,353
+1,227% +$2.87M 0.01% 595
2020
Q1
$182K Buy
8,588
+334
+4% +$7.44K ﹤0.01% 1773
2019
Q4
$185K Buy
8,254
+796
+11% +$17.4K ﹤0.01% 2009
2019
Q3
$151K Buy
+7,458
New +$147K ﹤0.01% 2194

Other funds holding GMAB

PNC Financial Services Group's GMAB Position: Q3 2026 in Review

PNC Financial Services Group increased its Genmab (GMAB) stake by 6% in Q3 2026, buying an estimated $41K and bringing the position to 23,017 shares worth $821K. The position accounts for ﹤0.01% of the portfolio, ranked #1442.

PNC Financial Services Group first reported a position in GMAB in Q3 2019 and has held it in 29 quarters since. The position peaked at $8.52M in Q3 2021. 333 funds tracked by Wall St. Rank hold GMAB as of Q3 2026.

  • PNC Financial Services Group held 23,017 shares of Genmab worth $821K as of Q3 2026.
  • PNC Financial Services Group bought 1,296 Genmab shares in Q3 2026, an estimated $41K.
  • Genmab made up ﹤0.01% of PNC Financial Services Group's portfolio in Q3 2026, its #1442 holding.
  • PNC Financial Services Group first reported a position in Genmab in Q3 2019 and has held it in 29 quarters since.
  • PNC Financial Services Group's Genmab position peaked at $8.52M in Q3 2021.
  • 333 funds tracked by Wall St. Rank held Genmab as of Q3 2026.

Based on PNC Financial Services Group's 13F filing for Q3 2026, filed 6 Nov 2026.